Not cancer · Austria
Coronary artery disease
How is it diagnosed today? Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. MedlinePlus
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.26 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Lifestyle changes and medicines; stents or bypass if needed. NHS
15 medicines are approved for this disease in Austria:
Show all 15
- Cangrelor (Kengrexal) – approved in 2015
- Clopidogrel (Clopidogrel Zentiva, Plavix, Clopidogrel Viatris) – approved in 1998
- Clopidogrel and acetylsalicylic acid (DuoPlavin, Clopidogrel / Acetylsalicylic acid Viatris, Clopidogrel/Acetylsalicylic acid Zentiva) – approved in 2010
- Colchicine (Colchicine Agepha Pharma, Colctab) – approved in 2026
- Enoxaparin (Inhixa, Lovenox, Enoxaparin sodium) – approved in 2016
- Eptifibatide (Eptifibatide Accord, Eptifibatide) – approved in 2016
- Evolocumab (Repatha) – approved in 2015
- Fondaparinux (Arixtra) – approved in 2002
- Ivabradine (Ivabradine Anpharm, Corlentor, Procoralan) – approved in 2005
- Prasugrel (Prasugrel Viatris, Efient, Effient) – approved in 2009
- Ranolazine (Ranexa, Aspruzyo Sprinkle) – approved in 2008
- Rivaroxaban (Rivaroxaban Viatris, Xarelto, Rivaroxaban Accord) – approved in 2008
- Telmisartan (Micardis, Tolura, Telmisartan Actavis) – approved in 1998
- Tenecteplase (Metalyse, TNKase) – approved in 2001
- Ticagrelor (Brilique, Brilinta, Ticagrelor Zydus) – approved in 2010
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (56)
- Acebutolol (Sectral, Acebutolol Teva) – approved for it in France
- Acenocoumarol (Sintrom) – approved for it in France
- Acetylsalicylic acid (Aspirin Cardio) – approved for it in Switzerland
- Alirocumab (Praluent) – approved for it in the US
- Alteplase (Activase, Actilyse) – approved for it in the US, Switzerland, and France
- Amlodipine (Norliqva, Sdamlo, Amlodipine Besylate) – approved for it in the US and France
- Amlodipine and atorvastatin (Caduet) – approved for it in the US
- Atenolol (Tenormin, Tenormine, Atenolol Biogaran) – approved for it in the US and France
- Atorvastatin (Atorvaliq, Atorvastatin Calcium) – approved for it in the US
- Atorvastatin and ezetimibe (Ezetimibe/Atorvastatine Biogaran) – approved for it in France
- Bempedoic acid (Nexletol) – approved for it in the US
- Bempedoic acid and ezetimibe (Nexlizet) – approved for it in the US
- Betaxolol (Kerlone, Betaxolol Eg) – approved for it in France
- Bisoprolol (Detensiel, Bisoprolol Eg, Bisoprolol Teva) – approved for it in France
- Bivalirudin (bivalirudin) – approved for it in the US
- Captopril (captopril, Captopril Viatris, Captopril Eg) – approved for it in the US and France
- Celiprolol (Celectol) – approved for it in France
- Dalteparin (Fragmin) – approved for it in the US
- Diltiazem (Tiazac Extended Release, Tildiem, Bi Tildiem L.p.) – approved for it in the US and France
- Ezetimibe (Ezetrol, Ezetimibe Zydus) – approved for it in France
- Ezetimibe and simvastatin (Vytorin, Inegy, Ezetimibe/Simvastatine Biogaran) – approved for it in the US and France
- Felodipine (Flodil L.p., Felodipine Sandoz L.p.) – approved for it in France
- Fluindione (Previscan) – approved for it in France
- Fluvastatin (Fluvastatin Sodium Er, Lescol L.p.) – approved for it in the US and France
- Gemfibrozil – approved for it in the US
- Glyceryl trinitrate (Nitrolingual, Nitriderm Tts, Nitrostat) – approved for it in the US, Switzerland, and France
- Icosapent ethyl (Vascepa) – approved for it in the US
- Isosorbide dinitrate (Isoket, Isosorbide Dinitrate) – approved for it in the US and Switzerland
- Heparin (Heparine Calcique Panpharma, Heparine Sodique Panpharma, Calciparine Sous Cutanee) – approved for it in France
- Isosorbide mononitrate (isosorbide mononitrate) – approved for it in the US
- Lisinopril (Qbrelis, Zestril, Lisinopril Eg) – approved for it in the US and France
- Lovastatin – approved for it in the US
- Metoprolol (Toprol Xl, Lopressor, Seloken) – approved for it in the US and France
- Molsidomine (Corvaton, Corvasal, Molsidomine Biogaran) – approved for it in Switzerland and France
- Nadolol (Nadolol, Corgard) – approved for it in the US and France
- Niacin – approved for it in the US
- Nicardipine (Nicardipine Hydrochloride) – approved for it in the US
- Nicorandil (Nicorandil Rivopharm, Nicorandil Zentiva) – approved for it in Switzerland and France
- Nifedipine (Procardia XL, Nifedipine Arrow L.p., Nifedipine Viatris L.p.) – approved for it in the US and France
- Perindopril (Perindopril Biogaran, Perindopril Erbumine, Perindopril Arrow) – approved for it in the US and France
- Nadroparin (Fraxiparine) – approved for it in France
- Perindopril and amlodipine (Perindopril Amlo Spirig HC, Perindopril-Amlodipin-Mepha Teva) – approved for it in Switzerland
- Pindolol (Visken Quinze) – approved for it in France
- Pravastatin (Pravastatin sodium, Pravastatine Eg) – approved for it in the US and France
- Propranolol (Propranolol Teva, Propranolol Eg) – approved for it in France
- Ramipril (Ramipril, Triatec, Ramipril Sandoz) – approved for it in the US and France
- Rosuvastatin and ezetimibe (Zenon, Quiloga) – approved for it in Switzerland and France
- Simvastatin (Zocor) – approved for it in the US
- Ticlopidine (Ticlopidine Eg) – approved for it in France
- Timolol (Timolol Maleate, Timacor) – approved for it in the US and France
- Tirofiban (Aggrastat, Agrastat, Tirofiban Medac) – approved for it in the US and France
- Trandolapril (Trandolapril, Odrik, Trandolapril Biogaran) – approved for it in the US and France
- Trimetazidine (Vastarel) – approved for it in France
- Verapamil (Isoptine L.p., Verapamil Eg L.p.) – approved for it in France
- Warfarin (Warfarin Sodium) – approved for it in the US
- Zofenopril (Zofenil) – approved for it in France
Being tested in people
26 open trials in Austria, 1030 worldwide. See the trials
- 1-month DAPT (Phase 3)
- 12-month DAPT (Standard of care) (Phase 3)
- Acetyl Salicylic Acid (ASA) (Phase 3)
- acetylsalicylic acid (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Dichloroacetate (DCA) (only single reports in people)
- Hyperthermia (only single reports in people)
- Ketogenic diet (only single reports in people)
- Mistletoe extract (only single reports in people)
- Ivermectin (animal studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
3 open trials in Austria with these filters, and 2 opening soon or by invitation
Blood Cell Gene Changes and Heart Damage After a Severe Heart Attack
NCT07615023 · ClinicalTrials.gov
- Innsbruck – Medical University of Innsbruck
Ages 18 to 75
Contact the trial teamTesting a heart risk score made for women aged 40 to 65 in Austria
NCT07849127 · ClinicalTrials.gov
- Klagenfurt – Anna Rab
Ages 40 to 65
Contact the trial teamStudying inflammation linked to clonal hematopoiesis in healthy people and people with related diseases
NCT07780552 · ClinicalTrials.gov
- Innsbruck – Medical University Innsbruck
Age 18 and over
Contact the trial teamTests artificial intelligence on blood cell data to predict heart attack
NCT06384846 · ClinicalTrials.gov
- Graz – Landeskrankenhaus Universitatsklinikum Graz
Age 18 and over
Contact the trial teamAnxiety and PTSD symptoms after a heart attack over time
NCT04130269 · ClinicalTrials.gov
- Graz – Medical University of Graz
Ages 19 to 90
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (125 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Using heart sounds to detect coronary artery disease and valve disease earlier
NCT07496775 · ClinicalTrials.gov
Countries: United Kingdom
- Cambridge, United Kingdom – Cambridge University NHS Foundation Trust
Age 18 and over
Contact the trial teamHeart and blood vessel risk in people with Crohn's disease and ulcerative colitis
NCT07095634 · ClinicalTrials.gov
Countries: Italy
- San Donato Milanese, Italy – IRCCS San Donato POliclinic
Age 16 and over
Contact the trial teamBlood tests and phone programs for heart, kidney and diabetes risk
NCT07820800 · ClinicalTrials.gov
Countries: Finland
- Savonlinna, Finland – Wellbeing Services County of South Savo (Eloisa) (provide social and healthcare services and emergency services in the Enonkoski, Hirvensalmi, Juva, Kangasniemi, Mikkeli, Mäntyharju, Pieksämäki, Puumala, Rantasalmi, Savonlinna ja Sulkava)
Ages 45 to 55
Contact the trial teamReal-Time Air Quality Information During Walking Exercise in Heart and Lung Rehabilitation
NCT07500948 · ClinicalTrials.gov
Countries: United Kingdom
- Leicester, United Kingdom – Glenfield Hospital, University Hospitals of Leicester NHS Trust, Groby Road
Age 18 and over
Contact the trial teamSmartphone AI help for reading heart tracings in emergency care
NCT07810686 · ClinicalTrials.gov
Countries: Switzerland
- Murten/Morat, Switzerland – Caserne des pompiers de Morat (Swiss French-speaking prehospital clinical research conference)
Age 18 and over
Contact the trial teamComparing two heart bypass surgeries in adults with coronary artery disease
NCT07314138 · ClinicalTrials.gov
Countries: Belgium, Netherlands
- Leuven, Belgium – University Hospitals Leuven
- Eindhoven, Netherlands – Catharina Hospital Eindhoven
Ages 18 to 85
Contact the trial teamStudying how coronary artery plaques lead to heart attacks and heart muscle damage
NCT07772570 · ClinicalTrials.gov
Countries: United Kingdom
- Oxford, United Kingdom – Oxford Heart Centre, John Radcliffe Hospital
Ages 18 to 90
Contact the trial teamTests a vegetarian diet's effect on immunity after heart attack
NCT06209723 · ClinicalTrials.gov
Countries: Netherlands
- Nijmegen, Netherlands – Radboudumc
Age 18 and over
Contact the trial teamComparing two adenosine doses in heart imaging for chronic coronary syndrome
NCT06578234 · ClinicalTrials.gov
Countries: Sweden
- Lund, Sweden – Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital
Age 40 and over
Contact the trial teamFollowing healthy middle-aged and older adults to study blood markers of later disease
NCT07743021 · ClinicalTrials.gov
Countries: Hungary
- Balatonfüred, Hungary – 04_DRC Balatonfüred_Drug Research Center LLC
- Békéscsaba, Hungary – 14_TP Békéscsaba_Trial Pharma LLC Békéscsaba
- Budapest, Hungary – 20_TP Budapest_Trial Pharma LLC Budapest
Age 40 and over
Contact the trial teamTesting a Blood Method to Detect Macrotroponin in Heart Attack Patients and Marathon Runners
NCT07726420 · ClinicalTrials.gov
Countries: Germany
- Munich, Germany – Technical University Munich
Age 18 and over
Contact the trial teamAI-assisted heart CT scans to estimate risk of future coronary events in adults
NCT07577609 · ClinicalTrials.gov
Countries: Ireland
- Galway, Ireland – Clinical Research Facility
Age 18 and over
Contact the trial teamFollowing heart artery scaffold implants in patients with coronary artery disease
NCT03327961 · ClinicalTrials.gov
Countries: Italy
- Agrigento, Italy – AO San Giovanni di Dio
- Bologna, Italy – Azienda Ospedaliera Universitaria di Bologna
- Bologna, Italy – U.O. Cardiologia, Ospedale Maggiore
Age 18 and over
Contact the trial teamTesting a new heart scanning method for people with heart attacks
NCT04458883 · ClinicalTrials.gov
Countries: United Kingdom
- Aberdeen, United Kingdom – Cardiovascular Research Facility
- Aberdeen, United Kingdom – University of Aberdeen and NHS Grampian
Age 20 and over
Contact the trial teamTests a smartphone 12-lead heart tracing device for heart attack
NCT06271577 · ClinicalTrials.gov
Countries: United Kingdom, United States
- Edinburgh, United Kingdom – University of Edinburgh
- Leeds, United Kingdom – Leeds General Infirmary
- Murray, United States – Intermountain Health
Age 18 and over
Contact the trial teamStudies heart blood flow with MRI during fluid challenge and exercise
NCT03854071 · ClinicalTrials.gov
Countries: United Kingdom
- Sheffield, United Kingdom – Sheffield Teaching Hospitals NHS FT
Ages 20 to 80
Contact the trial teamGut Bacteria Transfer for Diabetes and Heart Artery Disease
NCT07421947 · ClinicalTrials.gov
Countries: Switzerland
- Zurich, Switzerland – University Hospital Zurich
Ages 18 to 75
Contact the trial teamStudies whether wearable devices can track heart health and heart disease risk
NCT07401550 · ClinicalTrials.gov
Countries: Ireland
- Dublin, Ireland – Beacon Hospital
Age 18 and over
Contact the trial teamHeart CT scans for people with a family history of coronary artery disease
NCT07352111 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – Ospedale Galeazzi-Sant'Ambrogio IRCCS
Ages 40 to 70
Contact the trial teamHeart and metabolic problems in people with hormone-silent pheochromocytoma and paraganglioma
NCT07316075 · ClinicalTrials.gov
Countries: Greece
- Athens, Greece – NKUA
Age 18 and over
Contact the trial teamHeart rate lowering drugs before a heart CT scan for coronary artery disease
NCT07268170 · ClinicalTrials.gov
Countries: Denmark
- Herning, Denmark – University Clinic of Ischemic Heart Disease
Ages 30 to 80
Contact the trial teamTesting Genetic Risk Scores and Wearable Devices to Prevent Heart Disease
NCT05883878 · ClinicalTrials.gov
Countries: Italy
- Roma, Italy – Dipartimento Universitario di Scienze della Vita e Sanità Pubblica
Ages 40 to 69
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting a genetic risk score and a smartwatch app for heart disease prevention
NCT06911294 · ClinicalTrials.gov
Countries: Italy
- Rome, Italy – Studio Pasca
- Rome, Italy – Studio Colletti
- Rome, Italy – Studio Mammucari
Ages 40 to 69
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests metoprolol against placebo for blood flow in the heart's small vessels
NCT06864234 · ClinicalTrials.gov
Countries: Belgium
- Aalst, Belgium – OLV Cardiovascular Center Aalst
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamEye Scans to Study Small Blood Vessels in Heart Attacks With Normal Arteries
NCT07055152 · ClinicalTrials.gov
Countries: Italy
- Pisa, Italy – University of Pisa, Cisanello Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamQuick Blood Test for Heart Attack in Ambulances
NCT07008391 · ClinicalTrials.gov
Countries: Sweden
- Stockholm, Sweden – Ambulance care in greater Stockholm Ltd. (AISAB)
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamContactless device to measure artery stiffness and heart disease risk
NCT06984211 · ClinicalTrials.gov
Countries: Sweden
- Stockholm, Sweden – Neko Health Centre, Sibyllegatan
- Stockholm, Sweden – Atrium Health Care Centre
- Stockholm, Sweden – Neko Health Centre, Regeringsgatan
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTool to help people with heart artery disease weigh stents or surgery
NCT06567626 · ClinicalTrials.gov
Countries: United Kingdom
- Leicester, United Kingdom – University Hospitals of Leicester
- Leicester, United Kingdom – University of Leicester
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies whether common heart medicines work equally well across different ethnic groups
NCT03987633 · ClinicalTrials.gov
Countries: United Kingdom
- Wolverhampton, United Kingdom – Future Genetics, The Science Centre, Wolverhampton Science Park
Age 6 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamScreening working-age adults for chronic non-communicable diseases and their risk factors
NCT06812767 · ClinicalTrials.gov
Countries: Russia
- Moscow, Russia – National Medical Research Center for Therapy and Preventive Medicine
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting Oxygen Levels During Anaesthesia for Non-cardiac Surgery
NCT04808401 · ClinicalTrials.gov
Countries: Switzerland
- Bern, Switzerland – Bern University Hospital, Inselspital
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests genotype-guided clopidogrel alone after heart stent procedures
NCT05926271 · ClinicalTrials.gov
Countries: Netherlands
- Nieuwegein, Netherlands – St. Antonius Hospital
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamChecking heart bypass grafts with flow measurement during coronary surgery
NCT06471062 · ClinicalTrials.gov
Countries: Italy
- Roma, Italy – Fondazione Policlinico Gemelli IRCCS
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFinding causes of chest pain when heart arteries look clear
NCT06529861 · ClinicalTrials.gov
Countries: Denmark
- Copenhagen, Denmark – Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57, Frederiksberg, Denmark, 2000
Age 50 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamAI reads heart scans to screen for coronary artery disease without contrast dye
NCT06438393 · ClinicalTrials.gov
Countries: Portugal
- Porto, Portugal – Faculty of Medicine of Porto
Ages 18 to 100
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStenting versus bypass surgery in acute coronary syndrome with many narrowed arteries
NCT06279663 · ClinicalTrials.gov
Countries: Russia
- Novosibirsk, Russia – Anton
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFollowing heart attack patients with and without diabetes over time
NCT05046483 · ClinicalTrials.gov
Countries: Germany
- Düsseldorf, Germany – German Diabetes Center
Ages 18 to 80
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamHamburg study tracks health and imaging to spot chronic diseases early
NCT03934957 · ClinicalTrials.gov
Countries: Germany
- Hamburg, Germany – Universitätsklinikum Hamburg-Eppendorf
Ages 45 to 74
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamBlood Markers Compared With Heart Scans for Coronary Artery Disease
NCT02381301 · ClinicalTrials.gov
Countries: Netherlands
- Maastricht, Netherlands – Maastricht University Medical Center
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies cardiovascular health and heart disease using samples, scans and health records
NCT02804269 · ClinicalTrials.gov
Countries: Singapore
- Singapore, Singapore – National Heart Centre Singapore
Ages 16 to 90
Contact the trial team
Showing 40 of 125. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- In peoplePolarimetric Characterization of CCTA-Defined High-Risk Coronary Plaques: Linking Morphology to Fibrous Matrix Organization and Lipid Burden.Circ Cardiovasc Imaging · 2026-11-17
- ReviewCoronary Artery Bypass Graft versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of 29,554 Patients.J Chest Surg · 2026-11-17
- Saponarin: a shield against coronary heart disease-related myocardial injury via NF-κB pathway inhibition.Front Cardiovasc Med · 2026-11-02
- ReviewDiagnostic Performance and Clinical Outcomes of Coronary Computed Tomography Angiography Before Valve Surgery: A Systematic Review and Meta-analysis.CJC Open · 2026-08-13
- Association and limited incremental discrimination of the systemic coagulation-inflammation index for Gensini-defined coronary anatomical burden.Front Cardiovasc Med · 2026-11-02
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichischer Herzverband
Nationwide association for people with heart disease: guides, information on heart conditions, self-help groups and membership; regional branches.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- European Heart Network
Alliance of national heart foundations and associations (some representing patients); EU-level prevention policy and patient interest advocacy. Mixed, not purely patient-led.
- Global Heart Hub
Global umbrella of heart patient organisations; runs a Heart Failure Patient Network, awareness campaigns, advocacy and patient resources.
- World Heart Federation
Global cardiovascular federation (mixed: heart foundations, medical societies and advocacy groups, not purely patient-led); campaigns, policy and World Heart Day.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.